Novel probiotics and prebiotics: road to the market

•Novel foods and foods with health claims are often confused.•Regulatory framework of novel probiotic and prebiotics vary by geographical region.•Special focus is placed on the safety assessment of novel probiotics.•Suggestions for future novel probiotics and prebiotics are summarised. Novel probiot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current opinion in biotechnology 2015-04, Vol.32, p.99-103
Hauptverfasser: Kumar, Himanshu, Salminen, Seppo, Verhagen, Hans, Rowland, Ian, Heimbach, Jim, Bañares, Silvia, Young, Tony, Nomoto, Koji, Lalonde, Mélanie
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Novel foods and foods with health claims are often confused.•Regulatory framework of novel probiotic and prebiotics vary by geographical region.•Special focus is placed on the safety assessment of novel probiotics.•Suggestions for future novel probiotics and prebiotics are summarised. Novel probiotics and prebiotics designed to manipulate the gut microbiota for improving health outcomes are in demand as the importance of the gut microbiota in human health is revealed. The regulations governing introduction of novel probiotics and prebiotics vary by geographical region. Novel foods and foods with health claims fall under specific regulations in several countries. The paper reviews the main requirements of the regulations in the EU, USA, Canada and Japan. We propose a number of areas that need to be addressed in any safety assessment of novel probiotics and prebiotics. These include publication of the genomic sequence, antibiotic resistance profiling, selection of appropriate in vivo model, toxicological studies (including toxin production) and definition of target population.
ISSN:0958-1669
1879-0429
DOI:10.1016/j.copbio.2014.11.021